Simon, M.R., et al. Polyclonal Antibody Therapies for Clostridium difficile Infection. Antibodies 2014, 3, 272–288.

Michael R. Simon; Stephanie M. Chervin; Stephen C. Brown

doi:10.3390/antib4030278

,

and

¹

Secretory IgA, Inc., Ann Arbor, and Allergy and Clinical Immunology, William Beaumont Hospital, Royal Oak, MI 48073, USA

²

Secretory IgA, Inc., Ann Arbor, MI 48073, USA

³

Secretory IgA, Inc., Ann Arbor, MI 48073, USA

^*

Author to whom correspondence should be addressed.

Antibodies2015, 4(3), 278;https://doi.org/10.3390/antib4030278

Version Notes

Order Reprints

The authors wish to add the following to the acknowledgments of [1]:

“The authors acknowledge the contribution of Dr. Ricky Malhotra to our research efforts. Dr. Malhotra introduced the cell culture techniques into our lab and helped to establish the cell based assay. He also helped to prepare Figure 4.”

Reference

Simon, M.R.; Chervin, S.M.; Brown, S.C. Polyclonal Antibody Therapies for Clostridium difficile Infection. Antibodies 2014, 3, 272–288. [Google Scholar] [CrossRef]

© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).

Simon, M.R., et al. Polyclonal Antibody Therapies for Clostridium difficile Infection. Antibodies 2014, 3, 272–288.

Reference

Article Metrics

Citations

Article Access Statistics